PomDoctor, an online platform in China offering chronic disease management services, announced terms for its IPO on Tuesday.
The Guangzhou, China-based company plans to raise $25 million by offering 5 million ADSs at a price range of $4 to $6. At the midpoint of the proposed range, PomDoctor would command a market value of $592 million.
PomDoctor is an online medical services platform for chronic diseases in China. As of December 31, 2024, the company had over 212,800 cumulative contracted doctors that issued over 3 million prescriptions, as well as 699,000 transacting patients.
PomDoctor was founded in 2010 and booked $48 million in revenue for the 12 months ended December 31, 2024. It plans to list on the Nasdaq under the symbol POM. Joseph Stone Capital and Uphorizon are the joint bookrunners on the deal.
